Investing in Medtech's Future through Insight and Innovation Sharing
June 16-17, 2025
The popular 24th Annual Medtech MVP Venture & Partnering Conference gathers top medtech innovators, investors, and executives from around the nation to drive the industry’s future. This summit offers candid panel discussions, fireside chats, town hall forums, and ample networking time while diving into timely issues like capital raising, exit strategies, regulatory guidance, clinical trial design, and the prospects of the latest medical device technologies. With insights from diverse and experienced leaders and hands-on networking, Medtech MVP provides actionable strategies and fosters connections to drive innovation forward.
This year, we will focus on topics such as the macroeconomy for smaller companies under a new administration, an emerging technologies pitch contest and company showcase, raising capital, the M&A vs. IPO debate, advances in neurostimulation, the convergence of software and hardware, effective clinical trial design, how AI/Gen AI is used in MedTech organizations, regulatory guidance, and inspiring patient stories showcasing life-changing medical devices. Join leading medtech experts at this tailored event as we advance the industry through thought-sharing and networking.
Monday, June 16
Registration Open
Organizer's Welcome Remarks
Successfully Scaling and Commercializing a New Medtech Product
Successfully scaling a MedTech innovation requires strategic growth, regulatory expertise, and strong industry partnerships. This panel brings together experts to discuss key commercialization challenges, from securing investment to navigating FDA approval and accelerating market entry. Gain actionable insights to bring your medical device to market and drive success.
FIRESIDE CHAT:Venture Debt: Practical Strategies Learn practical strategies of venture debt financings from the perspectives of a medtech chief financial officer and debt capital advisor, including pros and cons, terms and costs.
Avio Medtech Pitch Contest
Frank Jaskulke, Vice President, Sales & Business Development, Avio Medtech
Join us for the Avio Medtech Pitch Contest, where the top finalists will present their innovative solutions to a panel of expert judges in a tightly scheduled showdown. Experience back-to-back pitches followed by engaging Q&A sessions, leading up to the highly anticipated announcement of the winner. Don't miss this electrifying finale, filled with groundbreaking ideas and insights into the future of medical technology.
Transition to Breakout Discussions
When Reimbursement Talks, People Listen: Optimizing Success and Avoiding Common RoadblocksReimbursement is the key factor in commercialization success. We will focus on the keys to optimizing successful reimbursement strategies and how to avoid common roadblocks that can slow adoption and concern investors.
The PowerHeal Success Story: From Idea to Exit in Three YearsA marketing case study which saw a product with a successful direct to consumer launch by understanding the audience, creating the right messaging and using data to drive marketing decisions.
R&D Problem Solving Workshop Sprint: Getting Devices to Market from Sketch to SalesRich Thompson, President of R&D and Engineering, VitaTek
This interactive workshop will take you behind the scenes of VitaTek’s Everything In-House approach to medical device development, with insights into how to turn cutting-edge concepts into real-world commercialized solutions in under 2 years.
Whether you’re a CXO, Engineer, Product Leader, Investor, or Innovator, this session is designed to equip you with more practical strategies and insights that can help accelerate your own innovation journey, including:
How to balance creativity and compliance when it comes to new medical device innovation
Pitfalls to avoid when starting a new medical device development project
Real-world case studies from VitaTek’s R&D playbook
What’s next: predictive insights into where the field is headed
Networking Welcome Reception
Close of Day
Tuesday, June 17
Registration and Morning Coffee
Organizer's Welcome Remarks
Late-Stage Investor Panel: What’s the Current Pulse on IPOs and M&A?
Jonathan Demchick, Co-Founder, Principal, Gilmartin Capital
As market dynamics shift, late-stage investors are reevaluating IPO and M&A strategies. This panel brings together industry experts to discuss the current investment landscape, key trends in public offerings, and evolving acquisition opportunities. Gain insights into what investors are looking for, how market conditions impact exit strategies, and what it takes to navigate today’s funding climate successfully.
Breakout DiscussionEvidence Development Challenges Posed by FDA and PayersThis session will focus on key differences in how FDA and payers evaluate the performance of medical technologies through their unique lenses. For emerging technologies in particular, widespread payer coverage routinely lags product approval. Tailoring a comprehensive evidence plan to address the needs of both stakeholders can help shorten this gap.
Breakout DiscussionLessons Learned and Future Advice for Medtech IPO NavigationLearn about the important considerations to follow from an expert panel across public and private medtech as they navigated/navigate/will navigate the world of successful public capital raising. Join Annie Wernig from J.P. Morgan's Healthcare Investment Bank, Kevin Hykes, President and CEO of CVRx, Mike Blue, CEO of Histosonics, Mike Kujak, President and CEO of Francis Medical, and Courtney Tygesson, Partner, Cooley, as they discuss this important topic.
Networking Coffee Break
Networking Lunch
PANEL DISCUSSION:Approaching Strategic Partners: Considerations for Corporate Venture CapitalJ.P. Peltier, Global Head, Healthcare, Piper Sandler
Securing the right strategic partner can accelerate growth, but engaging with corporate venture capital (CVC) requires a tailored approach. This panel explores what CVCs look for in potential investments, how to align with corporate priorities, and key considerations for structuring partnerships. Industry leaders will share strategies for navigating the CVC landscape and positioning your venture for successful collaboration.
Proactive Compliance in the age of FDA AI-based Submissions & Inspections
Adam Foresman, Co-Founder & CEO, Ryden Solutions
By continuously assessing your documents for quality and compliance issues in the background, you can focus efforts to getting devices shipped faster to the clinicians and patients that need them. Ryden Solutions discusses how you can save time and costs against FDA and EU requirements for any-sized medical device manufacturer in the MedTech world of evolving regulatory requirements and enforcement methods.
Critical Insights for Entrepreneurs & Investors: How Hospitals & ASCs Evaluate New Medical Devices and Cost-Benefit Decisions
Karen Ruszkoski, Vice President, Market Access and Reimbursement, Volta
Hospitals and ambulatory surgery centers (ASCs) face increasing pressure to balance innovation with cost efficiency when evaluating new medical devices. This panel will provide critical insights into how these institutions assess new technologies, weigh clinical and financial benefits, and make purchasing decisions. Entrepreneurs and investors will gain a deeper understanding of the key factors driving adoption, helping them better position their innovations for success in today’s value-driven healthcare landscape.
Ask the Pros: DuVal & AssociatesThis roundtable provides YOU the opportunity to direct the discussion with professionals at DuVal & Associates. Ask questions about FDA's regulatory process, overcoming submission obstacles, strategies for evidence development, and how to be appropriately aggressive yet compliant in sales and marketing practices under the Food, Drug & Cosmetic Act.
Ask the Reimbursement Experts: What Keeps You Up at Night?This roundtable provides you the opportunity to ask your reimbursement questions with Partners from the JD Lymon Group. Please ask your questions on securing new codes, securing incremental hospital payment at product launch, clinical trial reimbursement opportunities, where reimbursement “fits” in the product development life cycle, engaging CMS and other payers, or any other questions you may have
Creative and Successful Approaches for Obtaining Reimbursement Approval
Morgan Evans, Founder & CEO, Agitated Solutions
Securing reimbursement approval is a critical step in the commercialization of new medical technologies, yet the process is complex and ever-evolving. This panel will explore innovative and proven strategies for obtaining coverage, coding, and payment. Experts will share real-world insights on navigating regulatory hurdles, demonstrating value to insurers, and accelerating market adoption through effective reimbursement strategies.
The Next Generation of Neurostimulation Tech: Exploring Brain-Computer Interfaces in MedTech
Juan-Pablo Mas, Partner, Action Potential VC
Brain-computer interfaces (BCIs) are revolutionizing neurostimulation, opening new frontiers in treating neurological disorders and enhancing human capabilities. This panel brings together industry leaders, researchers, and investors to explore the latest advancements in BCI technology, its clinical applications, and the challenges of commercialization. Discover how cutting-edge innovation is shaping the future of MedTech and what it takes to bring next-generation neurostimulation devices to market.
Closing Networking Reception (Sponsorship Opportunity Available)
Close of Summit
Healthcare Investments and Exits—Q1’25 Update and 2025 Outlook
